USPTO patent # 6,073,627, “Apparatus for the application of ozone/oxygen for the treatment of external pathogenic conditions.” That patent indeed would have big value today especially with the ballooning increase in diabetes-related skin disorders, and yes, it is coming to the end of its useful life. Medizone management refused to pay the USPTO maintenance fees on it
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.